ArticleOncology letters2018

Histone deacetylase inhibitor AR-42 inhibits breast cancer cell growth and demonstrates a synergistic effect in combination with 5-FU.

Ruihao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.